Tarje O. Halvorsen
Trondheim, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Erratum to 'Evaluation of Radiation Therapy Treatment Plans in a Randomized Phase 2 Trial Comparing 2 Schedules of Twice-Daily Thoracic Radiation Therapy in Limited Stage Small Cell Lung Cancer.' International Journal of Radiation Oncology*Biology*Physics, Volume 120, Issue 2, 1 October 2024, Pages 332-342.
Journal: International journal of radiation oncology, biology, physics
Published: April 03, 2026
Gut microbiota alterations in patients with non-small-cell lung cancer undergoing chemoradiotherapy.
Gut microbiota alterations in patients with non-small-cell lung cancer undergoing chemoradiotherapy.
Journal: Molecular oncology
Published: March 23, 2026
Subtyping limited stage small cell lung cancer (LS SCLC) reveals inflammatory subtypes with improved chemoradiotherapy outcomes.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 16, 2026
Data Collection and Harmonization in Preterm Respiratory Research: Recommendations and Insights From PELICAN.
Journal: Pediatric pulmonology
Published: February 23, 2026
Osimertinib plus datopotamab deruxtecan in patients with EGFR-mutated advanced NSCLC after progression on first-line osimertinib: ORCHARD.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 19, 2026
ctDNA based MRD detection in stage III NSCLC treated with chemoradiotherapy and durvalumab.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: January 03, 2026
How does pulmonary function impact QoL in patients with locally advanced NSCLC treated with chemoradiotherapy and durvalumab?
Journal: Acta oncologica (Stockholm, Sweden)
Published: November 12, 2025
Blood-based tumor mutational burden as a biomarker in unresectable non-small cell lung cancer treated with chemoradiotherapy and durvalumab.
Journal: Frontiers in oncology
Published: August 07, 2025
Changes in use of radiotherapy for lung cancer - A Norwegian population-based study from 2000 until 2020.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 16, 2025
Associations between progastrin-releasing peptide (ProGRP) and neuron-specific enolase (NSE) and survival in patients with limited-stage small cell lung cancer (LS SCLC) receiving chemoradiotherapy (CRT).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 12, 2025
Toxicity Within 6 Months of Heterogeneous Fluorodeoxyglucose-Guided Radiotherapy Dose Escalation for Locally Advanced Non-Small Cell Lung Cancer in the Scandinavian Randomized Phase III NARLAL2 Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 18, 2025
High-Dose Versus Standard-Dose Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC: Final Survival Data, Long-Term Toxicity, and Relapse Patterns in a Randomized, Open-Label, Phase II Trial.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: February 14, 2025
Last Updated: 09/26/2026